New Novartis Drug Takes Aim At Tough-to-treat Malaria New Novartis Drug Takes Aim At Tough-to-treat Malaria

Novartis is taking aim at drug-resistant malaria – a growing global problem – by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news